Clinical trial

Biological Markers of Disease in the Prediction of Preterm Delivery…

NCT00340899 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed

Key facts

NCT number NCT00340899
Title Biological Markers of Disease in the Prediction of Preterm Delivery, Preeclampsia and Intra-Uterine Growth Retardation: A Longtitudinal Study
Official title Biological Markers of Disease in the Prediction of Preterm Delivery, Preeclampsia and Intra-Uterine Growth Restriction: A Longitudinal Study
Lead sponsor Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH
Status Completed
Study type Observational
Conditions Prenatal Care, Premature Birth
Enrollment 19,134
Start date Dec 4, 1997
Primary completion Jul 3, 2017
Completion Jul 13, 2017
First posted Jun 21, 2006
Last update posted Feb 24, 2023
Countries Chile

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies